Lindahl T
Genomics Proteomics Bioinformatics. 2013; 11(1):2-7.
PMID: 23453014
PMC: 4357663.
DOI: 10.1016/j.gpb.2012.12.001.
Morissette G, Flamand L
J Virol. 2010; 84(23):12100-9.
PMID: 20844040
PMC: 2976420.
DOI: 10.1128/JVI.01169-10.
Simpson K, Huxley C
Nucleic Acids Res. 1996; 24(23):4693-9.
PMID: 8972855
PMC: 146308.
DOI: 10.1093/nar/24.23.4693.
Calef E, Scotto dAbusco A, Bianchi E, GARGANO S, Fruscalzo A
Genetica. 1994; 94(2-3):249-53.
PMID: 7896143
DOI: 10.1007/BF01443438.
Lasky R, Troy F
Proc Natl Acad Sci U S A. 1984; 81(1):33-7.
PMID: 6320170
PMC: 344604.
DOI: 10.1073/pnas.81.1.33.
Evidence for integrated EBV genomes in Raji cellular DNA.
Anvret M, Karlsson A, Bjursell G
Nucleic Acids Res. 1984; 12(2):1149-61.
PMID: 6320116
PMC: 318562.
DOI: 10.1093/nar/12.2.1149.
Association between virus and cell DNA during latent cytomegalovirus infection in vitro.
Gadler H, Wahren B
Arch Virol. 1983; 75(4):291-8.
PMID: 6301407
DOI: 10.1007/BF01314895.
Papovaviral persistent infections.
Norkin L
Microbiol Rev. 1982; 46(4):384-425.
PMID: 6298589
PMC: 281554.
DOI: 10.1128/mr.46.4.384-425.1982.
Sequence complexity of circular Epstein-Bar virus DNA in transformed cells.
Griffin B, Bjorck E, Bjursell G, Lindahl T
J Virol. 1981; 40(1):11-9.
PMID: 6270367
PMC: 256591.
DOI: 10.1128/JVI.40.1.11-19.1981.
Oncogenic transformation by by equine herpesviruses. II. Coestablishment of persistent infection and oncogenic transformation of hamster embryo cells by equine herpesvirus type 1 preparations enriched for defective interfering particles.
Robinson R, Vance R, OCallaghan D
J Virol. 1980; 36(1):204-19.
PMID: 6255207
PMC: 353631.
DOI: 10.1128/JVI.36.1.204-219.1980.
Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication.
Colby B, Shaw J, ELION G, Pagano J
J Virol. 1980; 34(2):560-8.
PMID: 6246281
PMC: 288736.
DOI: 10.1128/JVI.34.2.560-568.1980.
Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines.
Harris A, Young B, Griffin B
J Virol. 1985; 56(1):328-32.
PMID: 2993664
PMC: 252545.
DOI: 10.1128/JVI.56.1.328-332.1985.
Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location.
Teo C, Griffin B
Proc Natl Acad Sci U S A. 1987; 84(23):8473-7.
PMID: 2825191
PMC: 299566.
DOI: 10.1073/pnas.84.23.8473.
Negative modulation of Epstein-Barr virus episomes by a human B-cell growth factor.
Morgan J, Roome A, Maizel A, Sharma S
J Virol. 1989; 63(7):3190-4.
PMID: 2542626
PMC: 250881.
DOI: 10.1128/JVI.63.7.3190-3194.1989.
Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes.
Rowe D, Hall L, Joab I, Laux G
J Virol. 1990; 64(6):2866-75.
PMID: 2159547
PMC: 249469.
DOI: 10.1128/JVI.64.6.2866-2875.1990.
Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
Wang F, Marchini A, Kieff E
J Virol. 1991; 65(4):1701-9.
PMID: 1848303
PMC: 239974.
DOI: 10.1128/JVI.65.4.1701-1709.1991.
When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.
Hurley E, Agger S, McNeil J, Lawrence J, Calendar A, Lenoir G
J Virol. 1991; 65(3):1245-54.
PMID: 1847452
PMC: 239896.
DOI: 10.1128/JVI.65.3.1245-1254.1991.
Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
Zimber-Strobl U, Suentzenich K, Laux G, Eick D, Cordier M, Calender A
J Virol. 1991; 65(1):415-23.
PMID: 1845900
PMC: 240532.
DOI: 10.1128/JVI.65.1.415-423.1991.
Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
Marchini A, Longnecker R, Kieff E
J Virol. 1992; 66(8):4972-81.
PMID: 1321281
PMC: 241347.
DOI: 10.1128/JVI.66.8.4972-4981.1992.
A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain.
Jankelevich S, Kolman J, Bodnar J, Miller G
EMBO J. 1992; 11(3):1165-76.
PMID: 1312463
PMC: 556559.
DOI: 10.1002/j.1460-2075.1992.tb05157.x.